Efficacy of Facial Botulinum Toxin A Injections in Alleviating Neuropsychiatric Symptoms in Parkinson's Disease Patients: An Open‐Label, Nonrandomized Controlled Trial
In summary, BTX-A demonstrates efficacy in reducing multiple neuropsychiatric symptoms (such as tension, anxiety, depression, sensitivity, etc.) in PD, with comparable effectiveness to CH, supporting its consideration as an alternative therapeutic option.
Authors
- Ming Wei (ORCID: https://orcid.org/0000-0001-5235-1281)
- Qiang Tong (ORCID: https://orcid.org/0000-0002-1259-7348)
- Xiu Yang
- Qiu Han
- Huimin Li
- Xiaofeng Zhu (ORCID: https://orcid.org/0009-0000-1745-2271)
Institutions
- Xuzhou Medical College (CN)
- Huaian First People’s Hospital (CN)
- Second People’s Hospital of Huai’an (CN)
Publication Details
- Journal
- Brain and Behavior
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/brb3.70806
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Xuzhou Medical University